Breast Neoplasm Female Clinical Trial
Official title:
Thermalogical Analysis of a Cohort of Women and Men Undergoing Mammographic Analysis.
This study is designed to evaluate the Sentinel BreastScan II as well as the analysis of data by Therma-Scan.
FirstSense Medical, LLC is a medical device company which has developed a breast cancer
screening device, the Sentinel BreastScan II [SBS II]. This radiation free device is being
developed to produce data which will be analyzed by Therma-Scan Reference Laboratory. Dr.
Hoekstra, CEO of Therma-Scan, is the author of a published paper based on breast thermal data
with a reported 95% sensitivity and 91% specificity. The SBS II examination will take
approximately 7 minutes.
This study is designed to evaluate the Sentinel BreastScan II as well as the analysis of data
by Therma-Scan. SBS II thermal breast data is an adjunctive aid to standard breast imaging.
Currently, mammography is one of the standards of care in screening for visible signs of
breast cancer. Breast thermology is the analysis of the heat signature data from an examined
breast. All study costs will be incurred by the sponsor. Study subjects will incur no cost to
participate. All scientific data revealed in this protocol will be used for the specific
objectives of the study. The SBS II is a non-significant risk device. There is no contact
with the subject during the entire procedure.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03980626 -
Study on Physical Activity's Relationship With Cancer and Cognition
|
N/A | |
| Completed |
NCT04329819 -
Satisfaction and QUality of Life After Breast REconstruction
|
||
| Recruiting |
NCT03323346 -
Phase II Trial of Disulfiram With Copper in Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT03900884 -
Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer
|
Phase 1 | |
| Completed |
NCT05042999 -
The Use of Virtual Reality During Breast Ultrasound-Guided Biopsy Procedures
|
N/A | |
| Not yet recruiting |
NCT03662633 -
Diagnosis Value of SEMA4C in Breast Cancer
|
||
| Recruiting |
NCT05075512 -
The Efficacy and Safety of Anlotinib Combined With Fulvestrant in Patients With Advanced Breast Cancer
|
Phase 2 | |
| Recruiting |
NCT04456855 -
Locoregional Surgery of the Primary Tumor in de Novo Stage IV Breast Cancer Patients
|
||
| Not yet recruiting |
NCT03629509 -
BEFORE Decision Aid Implementation Study
|
N/A | |
| Completed |
NCT04811378 -
HaemoCerTM Application in Breast Cancer Surgery
|
N/A | |
| Completed |
NCT03198442 -
Breast PET Feasibility
|
N/A | |
| Not yet recruiting |
NCT05577442 -
Trastuzumab, Pyrotinib Combined With Dalpiciclib and Endocrine Therapy for HR +/HER2 + Advanced Breast Cancer
|
Phase 2 | |
| Enrolling by invitation |
NCT04047823 -
Temperature and Injury in Radiotherapy Radiation Skin Injury
|
||
| Recruiting |
NCT05452213 -
Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients
|
Phase 4 | |
| Recruiting |
NCT05027321 -
Efficacy of Preparation in Self-Hypnosis by Anchoring Versus Conversational Hypnosis, Used Alone or Combined, in Patients Undergoing Breast Macrobiopsies
|
N/A | |
| Active, not recruiting |
NCT04812652 -
Digitally Distributed Yoga for Women Treated for Breast Cancer
|
N/A | |
| Active, not recruiting |
NCT03425838 -
Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer
|
Phase 3 | |
| Completed |
NCT05473026 -
Grateful Strides Toward Physical Activity and Well-Being for Black Breast Cancer Survivors
|
N/A | |
| Completed |
NCT04509063 -
Investigating Public Enthusiasm for Mammography Screening in Denmark
|
N/A | |
| Recruiting |
NCT05711030 -
Thoracic Paravertebral Block Anesthesia for Breast Cancer Surgery
|
N/A |